Publication | Closed Access

Identification of amentoflavone as a potent highly selective PARP-1 inhibitor and its potentiation on carboplatin in human non-small cell lung cancer

Selective Parp-1 InhibitorMedicinePharmacologyBronchial NeoplasmAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung CancerCancer ResearchDrug Discovery